Gastroenterology
Volume 129, Issue 2 , Pages 486-493 , August 2005

Mortality and Hospital Utilization for Hepatocellular Carcinoma in the United States

  • W. Ray Kim

      Affiliations

    • Division of Gastroenterology and Hepatology and Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota
    • Corresponding Author InformationAddress requests for reprints to: W. Ray Kim, MD, Gastroenterology and Hepatology (Mayo 16E), Mayo Clinic and Foundation, 200 First Street SW, Rochester, Minnesota 55905.fax: (507) 538-3974.
  • ,
  • Gregory J. Gores

      Affiliations

    • Division of Gastroenterology and Hepatology and Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
  • ,
  • Joanne T. Benson

      Affiliations

    • Division of Gastroenterology and Hepatology and Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
  • ,
  • Terry M. Therneau

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota
  • ,
  • L. Joseph Melton III

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota

Received 10 May 2004 ,Accepted 13 April 2005.

References 

  1. Parkin DM , Bray F , Ferlay J , Pisani P . Estimating the world cancer burden (Globocan 2000) . Int J Cancer . 2001;94:153–156
  2. Ferlay J , Bray FPP , Parkin DM . Globocan 2000 (Cancer incidence, mortality and prevalence worldwide) . IARC CancerBase No. 5. Lyon, France: IARC Press; 2001;
  3. El-Serag HB , Davila JA , Petersen NJ , McGlynn KA . The continuing increase in the incidence of hepatocellular carcinoma in the United States (an update) . Ann Intern Med . 2003;139:817–823
  4. El-Serag HB , Mason AC . Rising incidence of hepatocellular carcinoma in the United States . N Engl J Med . 1999;340:745–750
  5. Zaman SN , Melia WM , Johnson RD , Portmann BC , Johnson PJ , Williams R . Risk factors in development of hepatocellular carcinoma in cirrhosis (prospective study of 613 patients) . Lancet . 1985;1:1357–1360
  6. El-Serag HB , Mason AC . Risk factors for the rising rates of primary liver cancer in the United States . Arch Intern Med . 2000;160:3227–3230
  7. Kim WR , Benson JT , Therneau TM , Torgerson HA , Yawn BP , Melton LJ . U.S. Changing epidemiology of hepatitis B in a community . Hepatology . 2004;39:811–816
  8. Ruhl CE , Everhart JE . Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States . (see comment) Gastroenterology . 2003;124:71–79
  9. Williamson DF . Descriptive epidemiology of body weight and weight change in U.S. adults . Ann Intern Med . 1993;119:646–649
  10. Bruix J , Sherman M , Llovet JM , Beaugrand M , Lencioni R , Burroughs AK , et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver . (see comment) J Hepatol . 2001;35:421–430
  11. Anonymous. Cancer facts and figures 2003. Atlanta, GA: American Cancer Society; 2004;
  12. Kim W , Gross J , Poterucha J , Locke G , Dickson E . Outcome of hospital care of liver disease associated with hepatitis C in the United States . Hepatology . 2001;33:201–206
  13. Powell EE , Cooksley WG , Hanson R , Searle J , Halliday JW , Powell LW . The natural history of nonalcoholic steatohepatitis (a follow-up study of forty-two patients for up to 21 years) . Hepatology . 1990;11:74–80
  14. Clark JM , Diehl AM . Nonalcoholic fatty liver disease (an underrecognized cause of cryptogenic cirrhosis) . JAMA . 2003;289:3000–3004
  15. Marrero JA , Fontana RJ , Su GL , Conjeevaram HS , Emick DM , Lok AS . NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States . Hepatology . 2002;36:1349–1354
  16. Neuschwander-Tetri BA , Caldwell SH . Nonalcoholic steatohepatitis (summary of an AASLD Single Topic Conference (erratum appears in Hepatology 2003;38:536)) . Hepatology . 2003;37:1202–1219
  17. Kim WR , Ishitani MB , Dickson ER . Rising burden of hepatitis B in the United States (should “the other” virus be forgotten?) . Hepatology . 2002;36:222A
  18. Goldstein ST , Alter MJ , Williams IT , Moyer LA , Judson FN , Mottram K , et al.  Incidence and risk factors for acute hepatitis B in the United States, 1982–1998 (implications for vaccination programs) . J Infect Dis . 2002;185:713–719
  19. Liaw YF , Sung JJ , Chow WC , Farrell G , Lee CZ , Yuen H , et al.  Lamivudine for patients with chronic hepatitis B and advanced liver disease . N Engl J Med . 2004;351:1521–1531
  20. Alter MJ , Kruszon-Moran D , Nainan OV , McQuillan GM , Gao F , Moyer LA , et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 . N Engl J Med . 1999;341:556–562
  21. Anonymous. In: The burden of gastrointestinal diseases. Bethesda, MD: The American Gastroenterological Association; 2001;p. 41–60
  22. Anonymous. Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients (transplant data 1993–2002. 2003). Rockville, MD; Richmond, VA; Ann Arbor, MI: Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation; United Network for Organ Sharing, University Renal Research and Education Association; 2003;
  23. Freeman RB , Wiesner RH , Edwards EB , Harper AM , Merion RM , Wolfe RA . Results of the first year of the new liver allocation plan . Liver Transpl . 2004;10:7–15
  24. Kircher T , Nelson J , Burdo H . The autopsy as a measure of accuracy of the death certificate . N Engl J Med . 1985;313:1263–1269

 Supported by National Institutes of Health (DK-34238 and DK-60617).

PII: S0016-5085(05)00871-1

doi: 10.1053/j.gastro.2005.05.001

Gastroenterology
Volume 129, Issue 2 , Pages 486-493 , August 2005